Price Chart

Price Chart

Profile

Ainos, Inc. operates as a dual-platform biotech company, which engages in the development of artificial intelligence-enabled olfactory sensing technologies and immune therapeutics. The firm primarily focuses on the commercialization of AI Nose, an AI-based electronic olfaction system. It continues to develop VELDONA, a low-dose oral interferon platform. The company was founded on June 26, 1984 and is headquartered in Houston, TX.
URL http://www.ainos.com
Investor Relations URL N/A
HQ State/Province Texas
Sector Information Technology
Industry Technology Hardware, Storage & Peripherals
Equity Style Small Cap Growth
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Ainos, Inc. operates as a dual-platform biotech company, which engages in the development of artificial intelligence-enabled olfactory sensing technologies and immune therapeutics. The firm primarily focuses on the commercialization of AI Nose, an AI-based electronic olfaction system. It continues to develop VELDONA, a low-dose oral interferon platform. The company was founded on June 26, 1984 and is headquartered in Houston, TX.
URL http://www.ainos.com
Investor Relations URL N/A
HQ State/Province Texas
Sector Information Technology
Industry Technology Hardware, Storage & Peripherals
Equity Style Small Cap Growth
Next Earnings Release N/A
Last Earnings Release N/A
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A